These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18310567)

  • 21. Effectiveness and cost-benefit study to encourage herd owners in a cost sharing vaccination programme against bluetongue serotype-8 in Belgium.
    Cargnel M; Van der Stede Y; Haegeman A; De Leeuw I; De Clercq K; Méroc E; Welby S
    Transbound Emerg Dis; 2019 Jan; 66(1):400-411. PubMed ID: 30281942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reassortment of bluetongue virus vaccine serotypes in cattle.
    Van den Bergh C; Coetzee P; Venter EH
    J S Afr Vet Assoc; 2018 Dec; 89(0):e1-e7. PubMed ID: 30551703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The current status of research on an experimental inactivated bluetongue virus vaccine.
    Stott JL; Osburn BI; Barber TL
    Proc Annu Meet U S Anim Health Assoc; 1979; (83):55-62. PubMed ID: 233389
    [No Abstract]   [Full Text] [Related]  

  • 24. Bluetongue - where are we now? What are the challenges for the future?
    Vet Rec; 2008 Oct; 163(14):406-7. PubMed ID: 18935703
    [No Abstract]   [Full Text] [Related]  

  • 25. Vaccines for bluetongue and other orbiviruses from a regulatory viewpoint.
    Strating A
    Prog Clin Biol Res; 1985; 178():627-9. PubMed ID: 2989911
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of adaptive immune responses and heterologous protection induced by inactivated bluetongue virus vaccines.
    Breard E; Belbis G; Viarouge C; Nomikou K; Haegeman A; De Clercq K; Hudelet P; Hamers C; Moreau F; Lilin T; Durand B; Mertens P; Vitour D; Sailleau C; Zientara S
    Vaccine; 2015 Jan; 33(4):512-8. PubMed ID: 25500308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strong protection induced by an experimental DIVA subunit vaccine against bluetongue virus serotype 8 in cattle.
    Anderson J; Hägglund S; Bréard E; Riou M; Zohari S; Comtet L; Olofson AS; Gélineau R; Martin G; Elvander M; Blomqvist G; Zientara S; Valarcher JF
    Vaccine; 2014 Nov; 32(49):6614-21. PubMed ID: 25312275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA vaccine prime and recombinant FPV vaccine boost: an important candidate immunization strategy to control bluetongue virus type 1.
    Li J; Yang T; Xu Q; Sun E; Feng Y; Lv S; Zhang Q; Wang H; Wu D
    Appl Microbiol Biotechnol; 2015 Oct; 99(20):8643-52. PubMed ID: 26048472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defra's management of bluetongue vaccine stocks.
    Blackwell JM
    Vet Rec; 2009 May; 164(22):698-9; discussion 699-700. PubMed ID: 19483215
    [No Abstract]   [Full Text] [Related]  

  • 30. Assessment of cross-protection induced by a bluetongue virus (BTV) serotype 8 vaccine towards other BTV serotypes in experimental conditions.
    Martinelle L; Dal Pozzo F; Thys C; De Leeuw I; Van Campe W; De Clercq K; Thiry E; Saegerman C
    Vet Res; 2018 Jul; 49(1):63. PubMed ID: 30012223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bluetongue in western Turkey.
    Yonguç AD; Taylor WP; Csontos L; Worrall E
    Vet Rec; 1982 Aug; 111(7):144-6. PubMed ID: 6289510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative safety study of three inactivated BTV-8 vaccines in sheep and cattle under field conditions.
    Gethmann J; Hüttner K; Heyne H; Probst C; Ziller M; Beer M; Hoffmann B; Mettenleiter TC; Conraths FJ
    Vaccine; 2009 Jun; 27(31):4118-26. PubMed ID: 19410620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-propiolactone inactivated bivalent bluetongue virus vaccine containing Montanide ISA-71VG adjuvant induces long-term immune response in sheep against serotypes 4 and 16 even after 3 years of controlled vaccine storage.
    Zhugunissov K; Bulatov Y; Taranov D; Yershebulov Z; Koshemetov Z; Zhunushov A; Renukaradhya GJ; Tabynov K; Abduraimov Y
    Vet Microbiol; 2018 Nov; 226():23-30. PubMed ID: 30389040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep.
    Eschbaumer M; Hoffmann B; König P; Teifke JP; Gethmann JM; Conraths FJ; Probst C; Mettenleiter TC; Beer M
    Vaccine; 2009 Jun; 27(31):4169-75. PubMed ID: 19406189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Re: Detection of bluetongue virus genome after vaccination with an inactivated vaccine.
    Eschbaumer M; Wäckerlin R; Hoffmann B; Beer M
    Vaccine; 2010 Jan; 28(4):881-2. PubMed ID: 19925907
    [No Abstract]   [Full Text] [Related]  

  • 36. Why German farmers have their animals vaccinated against Bluetongue virus serotype 8: results of a questionnaire survey.
    Gethmann J; Zilow V; Probst C; Elbers AR; Conraths FJ
    Vaccine; 2015 Jan; 33(1):214-21. PubMed ID: 25454856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bluetongue vaccination in Europe.
    Zientara S; MacLachlan NJ; Calistri P; Sanchez-Vizcaino JM; Savini G
    Expert Rev Vaccines; 2010 Sep; 9(9):989-91. PubMed ID: 20822340
    [No Abstract]   [Full Text] [Related]  

  • 38. Bluetongue virus 'assembly kit' offers hope for improved vaccines.
    Vet Rec; 2011 Aug; 169(6):138. PubMed ID: 21821679
    [No Abstract]   [Full Text] [Related]  

  • 39. An inactivated vaccine for the control of bluetongue virus serotype 16 infection in sheep in Italy.
    Savini G; Ronchi GF; Leone A; Ciarelli A; Migliaccio P; Franchi P; Mercante MT; Pini A
    Vet Microbiol; 2007 Sep; 124(1-2):140-6. PubMed ID: 17499459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of a quadrivalent modified-live bluetongue virus vaccine in wildlife species.
    McConnell S; Morrill JC; Livingston CW
    Prog Clin Biol Res; 1985; 178():631-8. PubMed ID: 2989912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.